What Estrogen, Progesterone and Testosterone Do Beyond Your Reproductive System

Why do hormones show up in places you wouldn't expect?

Brain fog, dry skin and sluggish digestion don't sound like reproductive problems. Yet they can coincide with hormone shifts. Estrogen, progesterone and testosterone act on receptors (docking sites on cells) in bone, skin, brain, gut, muscle and fat, not only in the uterus and ovaries. Knowing this makes later symptom articles easier to follow, because symptoms that look unrelated to hormones can have a hormonal contributor.

Confidence varies by tissue. The evidence is strongest for estrogen's effects on bone, skin and where the body stores fat. For the brain, gut and testosterone, much of the research comes from animals, cells, or studies that only find correlations.

One caveat up front: almost all the human evidence comes from menopausal and postmenopausal women, where researchers can watch what happens when estrogen drops or is replaced. We know much less about what the ordinary menstrual cycle does to these systems.

Why are bones and skin where the evidence is strongest?

Bone is constantly remodeled: cells called osteoclasts dissolve old bone while other cells build new. Estrogen restrains the dissolving side¹. When estrogen falls, bone breakdown outpaces rebuilding, which is a major cause of postmenopausal osteoporosis. The exact cellular mechanism is still being worked out.

Replacement supports the link. Double-blind trials show hormone therapy prevents bone loss, and in the Women's Health Initiative it reduced fractures in postmenopausal women without osteoporosis. The Menopause Society's 2022 position statement calls the benefit-risk profile favorable under age 60 or within 10 years of menopause. It also notes that hormone therapy is approved for preventing bone loss, not treating osteoporosis². Testosterone contributes too: bone cells carry androgen receptors, and part of its effect comes after the body converts it to estrogen³. For more on this, see how estrogen loss affects bone density after menopause.

Skin follows a similar pattern. Losing estrogen at menopause is closely linked to losing skin collagen, and estrogen treatment has generally improved skin collagen, thickness, elasticity and hydration. Menopause appears to affect other connective tissues similarly, so skin changes may be a visible sign of something body-wide. The caveat: skin reviews call for large trials, so this is not a case for using estrogen on your skin.

What changes in metabolism and body fat around menopause?

Estrogen helps cells respond to insulin and curbs how much glucose the liver makes. The mechanism, which runs through a signaling protein called Foxo1, was mapped mostly in animal studies. It fits a human pattern: premenopausal women tend to have better insulin sensitivity and lower type 2 diabetes rates than men, an edge that fades after menopause.

Body composition changes are well documented. The menopausal transition is associated with more visceral fat (the fat packed around your organs), loss of lean mass and reduced ability to switch between burning fat and carbohydrate⁴. Muscle mass and strength decline in a pattern that coincides with menopause. Bioavailable testosterone, rather than total testosterone, has been linked to muscle in women, though that link is less firmly established.

Hormone therapy trials on glucose are mixed. Research suggests transdermal estradiol can improve insulin sensitivity, and adding certain progestogens may blunt that benefit. Research suggests fasting insulin and glucose tended to fall across the hormone treatment groups. Therapy may limit central fat gain, but it is not a weight-loss treatment.

How solid is the evidence on brain, gut and testosterone?

Estrogen influences neuron survival, synapses and the brain chemical systems tied to mood and memory. Much of that is animal or cell work, and how it plays out for memory and mood in people is only partly understood. Timing seems to matter. Longer-term estrogen plus progestogen has been linked to negative cognitive effects in older women. Current menopause guidance does not recommend hormone therapy to prevent dementia, and considers it cognitively neutral when started in early natural menopause².

Progesterone acts largely through allopregnanolone (a calming chemical the body makes from progesterone), which boosts GABA-A receptors, part of the brain's braking system. Research suggests progesterone can increase non-REM sleep, though much of that evidence comes from small studies in men. It isn't uniformly calming, though. Some early research suggests micronized progesterone can worsen sleep in some women, and progesterone may heighten activity in the brain's threat-detection area.

Microbial enzymes free estrogens that the liver packaged for excretion so they can be reabsorbed, a system called the estrobolome. Higher hormone levels are linked to greater microbial diversity, but correlation doesn't show which causes which. Progesterone relaxes gut muscle in lab studies, yet human data on gut transit are inconsistent.

Testosterone. It matters in women, acting directly and after conversion to estradiol. But studies are scarce, tests are imprecise and reference ranges aren't standardised.

How should you use this when reading about symptoms?

Sokkai provides guidance matched to your specific phase — not generic lifestyle advice. See how Sokkai works →

Treat it as a map. When a symptom turns up in bone, skin, joints, mood, sleep, digestion or weight, hormones are one plausible contributor among several, not the automatic answer. For cognitive symptoms in particular, see why perimenopause can cloud your thinking.

Weight your confidence accordingly. Bone, skin and fat-distribution findings are well supported. Brain, gut and testosterone findings are promising but not settled. Be wary of products that lean on animal, cell or microbiome-correlation evidence. Hormone therapy is a medical decision shaped by timing and personal risk, not a shortcut for skin, weight or memory. Treat testosterone tests that claim to diagnose "low T" in women with skepticism, since blood levels are a poor indicator. And a regular cycle is a different context from menopause, so don't assume menopausal findings describe yours.

What don't we know yet?

Almost everything above comes from menopausal or postmenopausal women, so we know little about what a normal cycle does to bone, brain, skin or metabolism. Whether estrogen protects the human brain is still debated: preclinical work is optimistic, while large trials in older women were neutral or negative. Whether weight and energy-expenditure changes come from menopause itself or from ageing and lifestyle is contested. For the gut, it's unclear whether microbiome differences cause or follow hormone differences, and no ideal microbiome has been identified. Whether androgen deficiency is a measurable clinical condition in women is disputed. Route (oral or transdermal), progestogen type and synthetic versus natural estrogen all change metabolic effects, so findings don't transfer cleanly between treatments.

When should you talk to your doctor?

Raise bone health if you went through menopause early, have had a fracture from a minor fall, or have lost noticeable height. If you're considering hormone therapy, the decision depends on your age, time since menopause and individual risk, so it needs a personal benefit-risk conversation. Sleep, mood or memory changes that disrupt daily life shouldn't be written off as "just hormones." Don't self-diagnose from low-accuracy testosterone or hormone tests; ask what a result would change. New, severe or sudden symptoms deserve evaluation for other causes.